Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Paediatrics & Child Health|May 3, 2021
Evaluation of compliance with the 2017 Canadian Paediatric Society Position Statement for the management of newborns at risk for early-onset sepsis: A retrospective cohort studyMarina Simeonova, Jolanta Piszczek, Sannifer Hoi, et al.
Plos One|July 17, 2014
The impact of drug reimbursement policy on rates of testosterone replacement therapy among older menJolanta Piszczek, Muhammad Mamdani, Tony Antoniou, et al.
JAMA Network Open|October 2, 2023
Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 ComplicationsColin R Dormuth, Jason D Kim, Anat Fisher, et al.
Lancet Regional Health. Americas|March 9, 2023
COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, CanadaTaraneh Bahremand, Jiayun Angela Yao, Christopher Mill, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 18, 2024
Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists' perspectivesKaren Dahri, Kimberley Sinclair Formerly MacNeil, Jolanta Piszczek, et al.
Vaccine|November 11, 2025
Cost-effectiveness of infant and maternal RSV immunization strategies, in British Columbia, CanadaJavad Taleshi, Marina Viñeta Paramo, Allison Watts, et al.
Lancet Regional Health. Americas|March 29, 2022
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort studySophie Stukas, George Goshua, Angus Kinkade, et al.
Blood Advances|February 24, 2022
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccinationAgnes Y Y Lee, Muntadhar Al Moosawi, Erica A Peterson, et al.
BMJ Open|August 3, 2025
Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settingsBanafshe Hosseini, Amanda Condon, Bruno R da Costa, et al.
Pageof 1